Cargando…
Hereditary thrombotic thrombocytopenic purpura and COVID‐19: Impacts of vaccination and infection in this rare disease
INTRODUCTION: Severe COVID‐19 is associated with an important increase of von Willebrand factor and mild lowering of ADAMTS13 activity that may, in the presence of a strong inflammatory reaction, increase the risk of acute thrombotic thrombocytopenic purpura (TTP). Although acute episodes of immune‐...
Autores principales: | Tarasco, Erika, von Krogh, Anne Sophie, Hrdlickova, Radomira, Braschler, Thomas R., Iwaniec, Teresa, Knöbl, Paul N., Hamada, Eriko, Pikovsky, Oleg, Farese, Stefan, Gutwein, Odit, Kessler, Petr, Schultz, Nina H., von Auer, Charis, Windyga, Jerzy, Friedman, Kenneth, Hrachovinova, Ingrid, George, James N., Matsumoto, Masanori, Schneppenheim, Reinhard, Lämmle, Bernhard, Kremer Hovinga, Johanna Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585384/ https://www.ncbi.nlm.nih.gov/pubmed/36284639 http://dx.doi.org/10.1002/rth2.12814 |
Ejemplares similares
-
The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017
por: van Dorland, Hendrika A., et al.
Publicado: (2019) -
Hypertension in patients with hereditary thrombotic thrombocytopenic purpura
por: Borogovac, Azra, et al.
Publicado: (2020) -
Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018) -
Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab
por: Falter, Tanja, et al.
Publicado: (2018) -
Daratumumab for immune thrombotic thrombocytopenic purpura
por: van den Berg, Jana, et al.
Publicado: (2022)